Emma Shittu

机构：Pfizer (United States), Pfizer (United Kingdom), Allergan (United Kingdom)

发表论文 13 篇 · 总被引 1415 次 · h-index 7

代表论文

• Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants (2023 · New England Journal of Medicine · 被引 996)
• Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial (2019 · Arthritis & Rheumatology · 被引 240)
• Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial (2025 · Obstetrics and Gynecology · 被引 109)
• Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine (2025 · Obstetrics and Gynecology · 被引 42)
• Specific B Cell Tolerance Is Induced by Cyclosporin A Plus Donor-Specific Blood Transfusion Pretreatment: Prolonged Survival of MHC Class I Disparate Cardiac Allografts (2000 · The Journal of Immunology · 被引 10)
• CONTRASTING OUTCOMES OF DONOR-SPECIFIC BLOOD TRANSFUSION (1998 · Transplantation · 被引 9)